Andrew Philp

Andrew Philp is an internationally recognized expert in mitochondrial metabolism, with a particular focus on skeletal muscle wasting disorders such as ageing, muscular dystrophy, and mitochondrial myopathy.1 He is currently the Head of the Biology of Ageing Program and convenor of the Centre for Healthy Ageing at the Centenary Institute.1 Prior to this, he was a Group Leader at the Garvan Institute of Medical Research from 2018 to 2022.3

Dr. Philp has an impressive academic background, having completed post-doctoral training at the University of Dundee (UK) and University of California Davis (USA) before establishing his independent research laboratory in 2012 at the University of Birmingham (UK).1 His research has been well-funded, with $10.1 million AUD in tier 1 grant funding as CIA and $26.4 million AUD as AI.1

His expertise extends to areas such as:

• Skeletal muscle metabolism
• Nutrition
• Insulin resistance
• Lipid and glucose metabolism
• Metabolic diseases2

Dr. Philp's work has been widely recognized, earning him several awards including New Investigator awards from the BBSRC (UK), American Physiological Society (USA), and RANK prize nutrition (UK).1 In 2019, he was awarded the prestigious Al and Val Rosenstrauss fellowship from the Rebecca Cooper Medical Research Foundation.1

As of 2022, Dr. Philp had 108 career publications with an H index of 44, resulting in 7201 total citations (4570 in the last 5 years) and an average of over 500 citations a year since 2014.1